Articles
Bright Raises $1.45 Million for Workplace Wellness Platform
Monday, September 12, 2022
Bright have created technology for organizations to provide virtual and live wellness classes for their employees.
Five Nova Scotia Start-Ups Selected for Latest GreenShoots Cohort
Tuesday, September 6, 2022
GreenShoots supports early stage companies in the agriculture, agri-food, bioeconomy, clean technology, and related sectors.
Arduro Sustainable Rubber: Using Clean Technology to Recycle Tires
Thursday, July 21, 2022
Arduro Sustainable Rubber has developed a clean technology process that turns waste tires back into high-grade, valuable raw materials.
Accelerate Highlights: Alan Uren, EndFirst Plans
Wednesday, June 29, 2022
EndFirst Plans have created OVERGantt, a project management software that solves the two critical factors in project success or failure – planning and communication.
GIT Announces Deal with Eastern Pacific Shipping
Wednesday, June 22, 2022
Graphite Innovation & Technologies (GIT) use graphene coatings to reduce corrosion and biofouling in water.
INTAG Bio Produces Plant Nutrients Sustainably
Tuesday, June 14, 2022
INTAG has developed technology to convert biological waste from fish and other animals into fertilizer.
Province Invests in Verschuren Centre Expansion
Thursday, June 9, 2022
The Province is investing in Nova Scotia's clean technology sector by supporting the Verschuren Centre for Sustainability in Energy and the Environment in Sydney to expand into a national biomanufacturing centre.
Innovacorp Wins Venture Capital Deal of the Year Award from CVCA
Thursday, May 19, 2022
Innovacorp has earned one of CVCA's most distinguished honours, Venture Capital Deal of the Year, for our investment in Meta Materials (META), a deal that resulted in a 35X return for us last year.
Pocket Finance Launches New Platform to Modernize Client Engagement for Financial Advisors
Wednesday, May 11, 2022
Pocket Finance is a platform that helps financial advisors and their customers improve engagement, data collection, and decision-making.
ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 Microspheres for Treatment of Liver Tumours
Tuesday, April 19, 2022
ABK Biomedical announced the first patient treated in ABK's First-in-Human study with Eye90 microspheres, a Y90 radioembolization device for the treatment of liver cancers.